Isoniazid Articles
Rifampicine improves compliance says trial
20 October 2008
First commercial launch from Akorn Strides
21 July 2008
Glenmark acquires Bouwer Bartlett, and is at forefront of India
16 January 2006
Sandoz plans to sell generic drugs to Spain's hospitals
11 April 2005
WHO/Novartis TB drug deal; other firms urged
5 January 2004
People with HIV need free TB drugs: WHO
28 July 2003
FDA Clears HMR's Priftin, First TB Drug In 25 Years
25 June 1998
Successful TOBI Launch Boosts PathoGenesis
28 May 1998
PathoGenesis Drug Shows Activity vs TB
14 October 1996
Mycobutin Enters TB Prophylaxis Trials
27 February 1995
Rifater Marketed In USA
14 November 1994
Mixed Results From US Companies In 2nd Qtr
8 August 1994
MMD RECEIVES FDA OK FOR RIFATER
13 June 1994
US NDA FILED FOR RIFATER
12 July 1993
BARR LABS REINTRODUCES TWO DRUGS
28 June 1993
MYCOBUTIN PROMOTION DEAL
17 May 1993
B-MS RECEIVES APPROVAL FOR NYDRAZID
1 March 1993
DURAMED'S ISONIAZID
6 April 1992
DURAMED'S ISONIAZID
6 April 1992
Showing 1-19 of 19 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
